A recent study that found there has been a massive increase in type 2 diabetes cases worldwide since 1990 is an indication ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

After easing diabetes and weight loss journey for many, the popular medications Ozempic and Wegovy have shown fresh promise ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

A new study found bariatric surgeries have recently dropped as the popularity of weight-loss drugs like Wegovy and Ozempic ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking.That's according to new research published by JAMA Psychiatry.In a study of around 228,000 people in Sweden who had ...

The weight loss drugs Ozempic and Wegovy may be beneficial for people struggling with alcohol addiction, a study published ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA ...

Hims & Hers Health launched a GLP-1 Supply Tracker to spotlight challenges in accessing obesity medications, addressing ...